4
Changes in Ownership
Apnimed, Inc. Filed Acc 0001193125-26-330510
Options or other derivatives
- Chief Financial Officer acquired 396,448 shares (grant or award)
- Chief Financial Officer returned 365,014 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelly Michael B Chief Financial Officer | 2026-08-03 | Returned to the company · Stock Option (Right to Buy) | −333,580 | 0 | D: show line 1 in the form | ||
| Kelly Michael B Chief Financial Officer | 2026-08-03 | Grant or award · Stock Option (Right to Buy) | +333,580 | 333,580 | D: show line 2 in the form | ||
| Kelly Michael B Chief Financial Officer | 2036-07-30 | Grant or award · Stock Option (Right to Buy) | +31,434 | 31,434 | D: show line 3 in the form | ||
| Kelly Michael B Chief Financial Officer | 2036-08-03 | Returned to the company · Stock Option (Right to Buy) | −31,434 | 0 | D: show line 4 in the form | ||
| Kelly Michael B Chief Financial Officer | 2036-08-03 | Grant or award · Stock Option (Right to Buy) | +31,434 | 31,434 | D: show line 5 in the form |
Loading xslF345X06/ownership.xml…